Drawing for AG OXYSALTS

USPTO serial 79237041

AG OXYSALTS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
AVENT, TEAGUE A
Law office
TMO LAW OFFICE 126

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with AG OXYSALTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Pamela B. Huff

Pamela B. Huff Schwegman Lundberg & Woessner P.A.P.O. Box 2938Minneapolis, MN 55402UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Sanitary preparations for medical purposes; medicated, sanitary or disinfecting preparations for the treatment of the feet, body and skin for use in association with acute and chronic wounds; medicinal and therapeutic preparations for the cleaning and debridement of wounds; disinfectant preparations for skin care being all purpose disinfectants, antiseptics, antifungal preparations; pharmaceutical preparations and medicated skin preparations for the treatment of scars and scars related skin conditions; medicated or pharmaceutical preparations for treating corns and chilblains; medicated preparations for curing ingrown toe-nails; medicated pads for the prevention of inflammation of the toes and of the thickening of skin calluses; wound dressings and materials for wound dressings, namely, absorbent pads for skin wounds; medical wound dressings for use in cleansing wounds, exfoliating skin and wounds and removing debris from skin and wounds; medicated bandages and dressings for the treatment of skin wounds, burns, diabetic ulcers, pressure ulcers, surgical wounds, vascular and circulatory system related skin diseases; medical bandages in the shape of a boot for dressing foot wounds; medical plasters for protecting, cushioning and moisturizing corns and blisters; medicated pads for the prevention of inflammation of the toes and of the thickening of skin calluses; medicated pads and insoles; bandages and dressings for the treatment of the skin impregnated with anti-fungal preparations and antimicrobial preparations and substances; dressings for the management of exudate from wounds; medical dressings; medical materials for dressings, namely, plasters, plaster rings, rings for corns being plasters; non-woven polyester medical dressings; non-woven medical dressings; foam wound dressings; absorptive foam dressings and pads for wound care; adhesive non-woven fabric being bandages for application and fixation of dressings; self-adhesive dressings; surgical dressings; gauze for dressings; bandages for dressings; pharmaceutical preparations for the treatment of wounds and skin wounds, namely, foils, meshes, compresses, permeable plastic films; medicated compresses; medicated cleansing pads for the skin; medicated absorbent pads for skin wounds; dressings and pads incorporating anti-fungal preparations; dressings and pads incorporating antimicrobial substances for dermatologic use; anti-fungal sprays; antibacterial sprays; bandages for skin wounds; all-purpose disinfectants; antiseptic preparations; sanitizing wipes; anti-fungal preparations; antimicrobial preparations for inhibiting and preventing bacteria; antimicrobials for dermatologic use; medical materials for dressings, namely, gauze, foam pads for medical purposes, hydrogel pads for medical purposes, hydrocolloid pads for medical purposes, medical adhesive and non-adhesive tape for retention and fixation of dressings, non-woven fabric being adhesive bandages for application and fixation of dressings; disinfectant preparations and antiseptic products, namely, wipes, tissues, sponges impregnated with disinfectant, sanitizing or antiseptic preparations; bandages for skin wounds; antimicrobial metal coatings for medical and dental applications; antimicrobial metal powders, foils, paints and coatings for medical, dental, wound and burn dressings applications; chemicals and chemical products and compounds for medical purposes, namely, chemical contraceptivesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 28, 2020FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 9, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 8, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 10, 2020OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 25, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 25, 2019OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 8, 2019MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 8, 2019ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 25, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 10, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 10, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 10, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 14, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 13, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 13, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 6, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 6, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 29, 2018RFNTREFUSAL PROCESSED BY IB—
Sep 13, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 13, 2018RFRRREFUSAL PROCESSED BY MPU—
Sep 5, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 4, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 31, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 26, 2018DOCKASSIGNED TO EXAMINER—
Jul 26, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 25, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jul 19, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance